This article needs additional citations for verification. (November 2018) |
![]() | |
Clinical data | |
---|---|
Trade names | Aclovate |
AHFS/Drugs.com | Monograph |
MedlinePlus | a604021 |
Routes of administration | Topical |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 3% systemically (topical) |
Metabolism | Hepatic |
Onset of action | Eczema: 5.3 - 13.9 days; Psoriasis: 6.7 - 14.8 days [1] |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
ChEBI | |
ChEMBL | |
Chemical and physical data | |
Formula | C22H29ClO5 |
Molar mass | 408.92 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Alclometasone is a synthetic corticosteroid for topical dermatologic use, possessing anti-inflammatory, antipruritic, and vasoconstrictive properties.[2][3]
The prodrug alclometasone dipropionate was originally marketed under the brand name Aclovate by GlaxoSmithKline as a topical cream and ointment. However, generic versions of the drug are available.